Search PDMR transactions

Notifier
Name of person with notification obligation
Yilmaz Mahshid
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Yilmaz Mahshid
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB (publ)
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Egetis Therapeutics AB SE0003815604 Acquisition 232,266 Quantity 3.8711 SEK 26/11/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Egetis Therapeutics AB SE0003815604 Acquisition 26/11/2025 NASDAQ STOCKHOLM AB 232,266 (Quantity) 3.8711 SEK
Total: 232,266
<< Back